Mitsubishi UFJ Asset Management
CRBU icon

Mitsubishi UFJ Asset Management’s Caribou Biosciences CRBU Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-42,266
Closed -$217K – 1578
2024
Q1 		$217K Sell
42,266
-1,936
-4% -$11.9K ﹤0.01% 954
2023
Q4 		$230K Buy
+44,202
New +$219K ﹤0.01% 995
2023
Q2 		– Sell
-29,861
Closed -$159K – 1116
2023
Q1 		$159K Buy
29,861
+2,180
+8% +$13.6K ﹤0.01% 1050
2022
Q4 		$183K Buy
+27,681
New +$246K ﹤0.01% 1028
2022
Q2 		– Sell
-15,652
Closed -$144K – 1154
2022
Q1 		$144K Buy
15,652
+1,730
+12% +$18.2K ﹤0.01% 1101
2021
Q4 		$213K Buy
+13,922
New +$271K ﹤0.01% 1074

Other funds holding CRBU

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
EWM
Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mitsubishi UFJ Asset Management's CRBU Position: Q2 2024 in Review

Mitsubishi UFJ Asset Management sold out of Caribou Biosciences (CRBU) in Q2 2024, closing a stake of 42,266 shares — an estimated $217K sold.

Mitsubishi UFJ Asset Management first reported a position in CRBU in Q4 2021 and held it in 6 quarters. The position peaked at $230K in Q4 2023. 140 funds tracked by Wall St. Rank hold CRBU as of Q2 2024.

  • Mitsubishi UFJ Asset Management reported no remaining Caribou Biosciences position as of Q2 2024 after selling out during the quarter.
  • Mitsubishi UFJ Asset Management sold 42,266 Caribou Biosciences shares in Q2 2024, an estimated $217K.
  • Mitsubishi UFJ Asset Management first reported a position in Caribou Biosciences in Q4 2021 and held it in 6 quarters.
  • Mitsubishi UFJ Asset Management's Caribou Biosciences position peaked at $230K in Q4 2023.
  • 140 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2024.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.